Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06859827

Role of CMR-FT in Assessment of HCM and Athlete's Heart.

The Role of Cardiac MRI Feature Tracking in Assessment of Hypertrophic Cardiomyopathy and Athlete's Heart.

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

Using cardiac MRI feature tracking to asses myocardial motion differences in athlete's heart and discovered hypertrophic cardiomyopathy patients to increase diagnostic accuracy of hypertrophic cardiomyopathy.

Detailed description

Cardiac MRI is the gold standard for assessing cardiac function without significant limitations of anatomical restrictions. CMR-FT helps in assessment of myocardial deformation on routinely obtained by steady state free precision (SSFP) cine images. CMR-FT is used in cardiac research and became common in clinical practice. It has been used in assessment of wide spectrum of cardiac diseases and provides for comprehensive and reliable assessments of heart function.

Conditions

Timeline

Start date
2024-12-15
Primary completion
2025-11-15
Completion
2025-12-15
First posted
2025-03-05
Last updated
2025-03-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06859827. Inclusion in this directory is not an endorsement.

Role of CMR-FT in Assessment of HCM and Athlete's Heart. (NCT06859827) · Clinical Trials Directory